Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Non Operating Income: 2011-2024

Historic Non Operating Income for Myriad Genetics (MYGN) over the last 14 years, with Dec 2024 value amounting to $1.1 million.

  • Myriad Genetics' Non Operating Income fell 141.67% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.4 million, marking a year-over-year decrease of 450.00%. This contributed to the annual value of $1.1 million for FY2024, which is 122.92% up from last year.
  • Myriad Genetics' Non Operating Income amounted to $1.1 million in FY2024, which was up 122.92% from -$4.8 million recorded in FY2023.
  • In the past 5 years, Myriad Genetics' Non Operating Income registered a high of $139.3 million during FY2021, and its lowest value of -$4.8 million during FY2023.
  • In the last 3 years, Myriad Genetics' Non Operating Income had a median value of $600,000 in 2022 and averaged -$1.0 million.
  • As far as peak fluctuations go, Myriad Genetics' Non Operating Income spiked by 810.46% in 2021, and later slumped by 900.00% in 2023.
  • Over the past 5 years, Myriad Genetics' Non Operating Income (Yearly) stood at $16.2 million in 2020, then reached $15.3 million in 2020, then surged by 810.46% to $139.3 million in 2021, then crashed by 99.57% to $600,000 in 2022, then slumped by 900.00% to -$4.8 million in 2023, then spiked by 122.92% to $1.1 million in 2024.